TRISTEL PLC LS-01
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments, Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for … Read more
TRISTEL PLC LS-01 (R1V) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, TRISTEL PLC LS-01 (R1V) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
TRISTEL PLC LS-01 - Net Assets Trend (None–None)
This chart illustrates how TRISTEL PLC LS-01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for TRISTEL PLC LS-01 (None–None)
The table below shows the annual net assets of TRISTEL PLC LS-01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to TRISTEL PLC LS-01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
TRISTEL PLC LS-01 Competitors by Market Cap
The table below lists competitors of TRISTEL PLC LS-01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shenzhen Ruihe Construction Decoration Co Ltd
SHE:002620
|
$199.27 Million |
|
Nam Kim Steel JSC
VN:NKG
|
$199.30 Million |
|
Rusoro Mining Ltd
PINK:RMLFF
|
$199.32 Million |
|
Unico Silver Ltd
AU:USL
|
$199.32 Million |
|
Guangdong Redwall New Materials Co Ltd
SHE:002809
|
$199.22 Million |
|
Jinling Hotel Corp Ltd
SHG:601007
|
$199.20 Million |
|
Zhongxing Shenyang Commercial Building Group Co Ltd
SHE:000715
|
$199.18 Million |
|
Phoenix Pioneer technology Co., Ltd.
TWO:6920
|
$199.16 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in TRISTEL PLC LS-01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares TRISTEL PLC LS-01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently TRISTEL PLC LS-01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares TRISTEL PLC LS-01's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $9,394,036,854
- Average return on equity (ROE) among peers: 4.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| TRISTEL PLC LS-01 (R1V) | €- | N/A | N/A | $199.25 Million |
| Modern Dental Group Limited (1MD) | $2.36 Billion | 15.30% | 0.55x | $193.75 Million |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $482.88 Million |
| Alcon Inc. (2U3) | $19.26 Billion | 1.95% | 0.45x | $33.73 Billion |
| Shofu Inc. (69W) | $35.51 Billion | 8.83% | 0.23x | $215.32 Million |
| 7VG (7VG) | $176.36 Million | 14.92% | 1.12x | $684.88 Million |
| Bio-gate AG (BIG1) | $4.25 Million | -42.46% | 0.46x | $2.79 Million |
| Paul Hartmann AG (PHH2) | $690.37 Million | 10.65% | 0.81x | $776.29 Million |
| Sartorius AG VZO O.N. (SRT) | $497.08 Million | 9.76% | 1.56x | $6.78 Billion |
| Shandong Weigao Group Medical Polymer Company Limited (UK2) | $25.34 Billion | 8.16% | 0.37x | $1.36 Billion |